Within the field of biotechnology, the production of recombinant proteins in various prokaryotic and eukaryotic expression systems represents a mature and attractive technological field with strong employment prospects. It is also a very important area of research in which many challenges remain to be addressed. The bioproduction of biopharmaceuticals (recombinant proteins as well as monoclonal antibodies) is a major issue not only in human therapeutics but also in numerous fields of biotechnology (environmental, industrial, agricultural, marine, etc.). Before designing any biological drug that involves a bioproduction step, it is essential to understand the various eukaryotic and prokaryotic expression systems used in biotechnology, as well as to have a comprehensive overview of the landscape and challenges of bioproduction in France, Europe, and around the world.
This course unit consists of interactive lectures. It is taught by various faculty members and industry professionals working in the field.
